CCL2 and non-small cell lung carcinoma: In this condition, we predicted that the regulation of resveratrol on ANPEP, CD69, ITGAL, PTPRC, CD34, ITGA1, CCL2, and SOX2 expression were beneficial to the treatment of NSCLC.